1. Home
  2. QRTEA vs NLSP Comparison

QRTEA vs NLSP Comparison

Compare QRTEA & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QRTEA
  • NLSP
  • Stock Information
  • Founded
  • QRTEA 1991
  • NLSP 2015
  • Country
  • QRTEA United States
  • NLSP Switzerland
  • Employees
  • QRTEA N/A
  • NLSP N/A
  • Industry
  • QRTEA Catalog/Specialty Distribution
  • NLSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • QRTEA Consumer Discretionary
  • NLSP Health Care
  • Exchange
  • QRTEA Nasdaq
  • NLSP Nasdaq
  • Market Cap
  • QRTEA 239.9M
  • NLSP 243.8M
  • IPO Year
  • QRTEA N/A
  • NLSP 2021
  • Fundamental
  • Price
  • QRTEA $0.62
  • NLSP $5.28
  • Analyst Decision
  • QRTEA
  • NLSP
  • Analyst Count
  • QRTEA 0
  • NLSP 0
  • Target Price
  • QRTEA N/A
  • NLSP N/A
  • AVG Volume (30 Days)
  • QRTEA 2.8M
  • NLSP 26.9K
  • Earning Date
  • QRTEA 11-01-2024
  • NLSP 10-18-2024
  • Dividend Yield
  • QRTEA N/A
  • NLSP N/A
  • EPS Growth
  • QRTEA N/A
  • NLSP N/A
  • EPS
  • QRTEA N/A
  • NLSP N/A
  • Revenue
  • QRTEA $10,371,000,000.00
  • NLSP N/A
  • Revenue This Year
  • QRTEA N/A
  • NLSP N/A
  • Revenue Next Year
  • QRTEA N/A
  • NLSP N/A
  • P/E Ratio
  • QRTEA N/A
  • NLSP N/A
  • Revenue Growth
  • QRTEA N/A
  • NLSP N/A
  • 52 Week Low
  • QRTEA $0.40
  • NLSP $4.08
  • 52 Week High
  • QRTEA $1.80
  • NLSP $40.60
  • Technical
  • Relative Strength Index (RSI)
  • QRTEA 54.12
  • NLSP 45.46
  • Support Level
  • QRTEA $0.58
  • NLSP $4.72
  • Resistance Level
  • QRTEA $0.70
  • NLSP $5.50
  • Average True Range (ATR)
  • QRTEA 0.04
  • NLSP 0.64
  • MACD
  • QRTEA 0.01
  • NLSP 0.05
  • Stochastic Oscillator
  • QRTEA 46.73
  • NLSP 41.67

About QRTEA Qurate Retail Inc. Series A

Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, using their televised shopping programs and via the Internet through their websites and mobile applications; QVC International segment markets and sells a wide variety of consumer products in several foreign countries, using its televised shopping programs and via the Internet through its international websites and mobile applications; and Zulily markets and sells a wide variety of consumer products in the United States and several foreign countries. Geographically, the company operates in U.S, which generates key revenue, Japan, Germany and other regions.

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

Share on Social Networks: